TSE:4974Biotechs
Takara Bio Q3 Loss Of ¥2.7b Tests Bullish Profitability Narratives
Takara Bio Q3 2026 earnings snapshot
Takara Bio (TSE:4974) has posted another loss in Q3 2026, with revenue of ¥9.6b and basic EPS of ¥22.49 in the red, alongside a trailing twelve month EPS of ¥59.79 in the red on revenue of ¥44.1b. The company has seen quarterly revenue hold around the ¥9.3b to ¥9.6b range over the last three quarters, while quarterly EPS moved from ¥12.55 in the red in Q1 2026 to ¥44.85 in the red in Q2 and ¥22.49 in the red in Q3. This keeps the focus squarely on how...